FDA Inspection
Synapse Labs Pvt. Ltd.Synapse Labs Pvt. Ltd. – FDA Inspection, Feb 21, 2020
Record Details
This FDA Inspection record concerns Synapse Labs Pvt. Ltd., with an inspection on February 21, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Synapse Labs Pvt. Ltd.
- Inspection Date
- February 21, 2020
- Product Type
- Drugs
View Company Profile
ID · e9f74844-00d9-4408-a2fa-9ae8849f2cbd
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1123667
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Synapse Labs Pvt. Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| March 9, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| November 25, 2017 | Not classified | Office of Inspections and Investigations | |
| August 2, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Synapse Labs Pvt. Ltd.
- FDA Inspection 1201266 - 2023-03-09
- FDA Inspection 1036640 - 2017-11-25
- FDA Inspection 1030877 - 2017-08-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.